Etrasimod (Velsipity)

Indications

UC in adults

Contraindications

Active malignancy; heart failure, stroke or unstable angina in previous six months; immunodeficiency. Use with caution in elderly patients; cerebrovascular disease; chronic obstructive pulmonary disease; severe respiratory disease; severe sleep aponoea; diabetes; uncontrolled high blood pressure; retinal disease; uveitis. Avoid during pregnancy and breasteeding and in severe hepatic impairment. | Potential side effects: Slow heartbeat; headache; high blood pressure/cholesterol; low white blood cell count; cystitis; dizziness

Preparations Available

Oral tablet

Quantity

Dose: 2mg once daily, with food for first 3 days, then with or without food; if treatment interrupted for more than 7 days, resume with food for first 3 days

Sizes Available

28 2mg tablets, £843.84

Price

2mg tablets (28), £843.84

More on: Biologics